Kronos Bio Inc - Rasio nilai perusahaan marang dodolan KRON

Simbol resmi perusahaan kronosbio.com (KRON)

Kronos Bio, Inc. (KRON) develops small molecules to block previously inaccessible cancer drivers using proprietary gene network analysis. The historical EV/Sales ratio reflects the impact of high scientific barriers and clinical trial costs, where determines the current value of the metric. The company is advancing precision medicine, focusing on identifying new oncogenic pathways for the therapy of complex diseases.

Kronos Bio Corporation (KRON): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Kronos Bio Corp - rincian analitis lan metrik utama (KRON)

Pambiji fundamental perusahaan:KRON, kronosbio.com
Produk sing diprodhuksi Kronos Bio Inc

To minimize risks amid uncertainty, it is crucial for investors to evaluate the enterprise value-to-revenue ratio, which reflects the current total value-to-revenue level at . While this indicator measures the market premium paid for an asset, it is secondary for Kronos Bio, Inc. (KRON), as capitalization depends on the success of early clinical trials rather than current sales.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|CMRX: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCC|Nilai perusahaan marang pendapatan g1therapeutics.com GTHX|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales